Key points are not available for this paper at this time.
If replicated, our findings suggest great potential of including steroids into existing breast cancer risk assessment tools.
Houghton et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: